Novel Latest Drugmaker Sued By Purdue Over Insomnia Drug

Law360, New York (September 12, 2012, 8:46 PM EDT) -- Purdue Pharmaceutical Products LP hit Novel Laboratories Inc. with a patent infringement suit Tuesday as part of its ongoing battle to protect its insomnia treatment Intermezzo, claiming the generic drugmaker's bid to produce its own version of the drug violates Purdue's licensing rights to the product.

Purdue alleges that Novel’s bid to secure regulatory approval to manufacture an Intermezzo clone violates its patent rights, echoing claims Purdue made in two other suits the drugmaker leveled against other drugmakers late last month. The patent at issue —...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.